Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
06/29/2000 | WO2000037648A1 Protective antigen of group a streptococci (spa) |
06/29/2000 | WO2000037646A2 Group b streptococcus proteins, and their use |
06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
06/29/2000 | WO2000037642A1 Method of enhancing the biological activity of ligands |
06/29/2000 | WO2000037641A2 Vascular endothelial growth factor-x |
06/29/2000 | WO2000037640A2 Compositions and methods for the treatment of tumor |
06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
06/29/2000 | WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth |
06/29/2000 | WO2000037635A2 Genetic suppressor elements against human immunodeficiency virus |
06/29/2000 | WO2000037627A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037626A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037625A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037624A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037623A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037622A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037621A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
06/29/2000 | WO2000037619A2 Mutant epoxide hydrolases |
06/29/2000 | WO2000037615A1 Recombinant synthesis of beta-lipotropin and other peptides |
06/29/2000 | WO2000037614A2 Variants of egiii-like cellulase and compositions thereof |
06/29/2000 | WO2000037613A2 Human akt-3 |
06/29/2000 | WO2000037610A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
06/29/2000 | WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
06/29/2000 | WO2000037608A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
06/29/2000 | WO2000037599A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
06/29/2000 | WO2000037504A2 Human monoclonal antibodies to ctla-4 |
06/29/2000 | WO2000037493A2 Type iii secretion system antigens from bordetella pertussis |
06/29/2000 | WO2000037491A2 Dnas encoding proteins with signal sequences |
06/29/2000 | WO2000037490A2 Outer surface proteins, their genes, and their use |
06/29/2000 | WO2000017221A9 Method of measuring protein-protein interactions in living cells |
06/29/2000 | WO2000015809A3 Uracil permease from arabidopsis as herbicidal target gene |
06/29/2000 | WO2000012726A3 Rationally designed heparinases derived from heparinase i and ii |
06/29/2000 | WO2000012542A3 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties |
06/29/2000 | WO2000008180A3 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS |
06/29/2000 | WO2000008145A3 Novel genes in control of hematopoiesis |
06/29/2000 | WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein |
06/29/2000 | WO2000002996A3 Recombinant constructs and systems for secretion of proteins via type iii secretion systems |
06/29/2000 | WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
06/29/2000 | WO2000000610A3 Human signal peptide-containing proteins |
06/29/2000 | WO2000000594A3 Human transferases |
06/29/2000 | WO1999066028A3 Genes for the biosynthesis of epothilones |
06/29/2000 | WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
06/29/2000 | DE19859059A1 Production of Bdellovibrio bacteriovorus cell suspensions using different host bacterium culture media to produce either bdellocysts or vegetative cells |
06/29/2000 | CA2776920A1 Method for producing ascorbic acid intermediates |
06/29/2000 | CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
06/29/2000 | CA2357004A1 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
06/29/2000 | CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
06/29/2000 | CA2356764A1 Type iii secretion system antigens from bordetella pertussis |
06/29/2000 | CA2356215A1 Human monoclonal antibodies to ctla-4 |
06/29/2000 | CA2355836A1 Genetic suppressor elements against human immunodeficiency virus |
06/29/2000 | CA2355604A1 Novel variant egiii-like cellulase compositions |
06/29/2000 | CA2355402A1 Recombinant synthesis of beta-lipotropin and other peptides |
06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
06/29/2000 | CA2354846A1 Method of enhancing the biological activity of ligands |
06/29/2000 | CA2354843A1 Outer surface proteins, their genes, and their use |
06/29/2000 | CA2354369A1 Complementary dna's encoding proteins with signal peptides |
06/29/2000 | CA2354135A1 Group b streptococcus proteins, and their use |
06/29/2000 | CA2354074A1 Method of identifying a psychotropic agent using differential gene expression |
06/29/2000 | CA2354030A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
06/29/2000 | CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth |
06/29/2000 | CA2353775A1 Compositions and methods for the treatment of tumor |
06/28/2000 | EP1013768A1 Mutant epoxide hydrolases |
06/28/2000 | EP1013766A2 Peptides for the detection of HIV-1-Group O |
06/28/2000 | EP1013765A1 Gene and method for producing L-amino acids |
06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
06/28/2000 | EP1013758A2 Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme |
06/28/2000 | EP1013757A2 Attenuated forms of bovine viral diarrhea virus |
06/28/2000 | EP1013665A1 Novel polypeptide having water channel activity and dna sequence |
06/28/2000 | EP1012333A1 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23 |
06/28/2000 | EP1012323A1 A method for the production of dicarboxylic acids |
06/28/2000 | EP1012315A1 Recombinant vectors |
06/28/2000 | EP1012311A1 G protein chimeras |
06/28/2000 | EP1012310A1 Fusion proteins comprising coiled-coil structures |
06/28/2000 | EP1012309A2 Chimeric polypeptides containing chemokine domains |
06/28/2000 | EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
06/28/2000 | EP1012306A2 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
06/28/2000 | EP1012303A1 Factor x deletion mutants and analogues thereof |
06/28/2000 | EP1012302A1 Human nucleotide pyrophosphohydrolase |
06/28/2000 | EP1012298A1 Yeast strains for the production of lactic acid |
06/28/2000 | EP1012296A2 Mammalian thioredoxin |
06/28/2000 | EP1012294A2 Microbial genes for secreted beta-glucuronidases, gene products and uses thereof |
06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
06/28/2000 | EP1012292A1 Ntn-2 member of tnf ligand family |
06/28/2000 | EP1012289A1 A recombinant expression vector of human parathyroid hormone using phosphoribulokinase as a fusion partner |
06/28/2000 | EP1012288A1 Novel human cystatin-like protein |
06/28/2000 | EP1012283A1 Mage-3 peptides presented by hla class ii molecules |
06/28/2000 | EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide |
06/28/2000 | EP1012280A1 Trimerising module |
06/28/2000 | EP1012279A1 Mitofusin genes and their uses |
06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
06/28/2000 | EP1012274A1 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap02-l) |
06/28/2000 | EP1012272A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124 |
06/28/2000 | EP1012266A1 Galectin 8, 9, 10 and 10sv |
06/28/2000 | EP1012265A1 Repressed trans-activator system for characterization of protein-protein interactions |
06/28/2000 | EP1012263A1 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012262A1 Human frezzled-like protein |
06/28/2000 | EP1012261A1 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012260A1 Interleukin-20 |
06/28/2000 | EP1012251A1 Protease variants and compositions |
06/28/2000 | EP1012248A1 Novel thermophilic polymerase iii holoenzyme |
06/28/2000 | EP1012246A1 Fermentation method with continuous mass cultivation of ciliates (protozoa) for producing biogenous valuable substances |